Graduated in Biochemistry from the University of Valencia (2013) with a Master Degree in Experimental Biomedicine (2014) by Universidad de Castilla-La Mancha and Master in Clinical Trial Management & Monitoring by Colegio de Médicos de Barcelona (2015). She started her doctoral thesis in January 2016 under Dr. Francisco Pérez Vizcaíno and Dr. Ángel Cogolludo Torralba supervision at the Pharmacology & Toxicology Department of Medicine School of Universidad Complutense de Madrid (UCM). She was awarded with CIBERES PhD fellowship to investigate the regulation of ion channel in the vasculature and their implication in cardiovascular and respiratory diseases. She obtained her PhD in September 2020 with Cum Laude, International Mention, and the Extraordinary UCM Medicine School PhD Award. In January 2021, she moved to Dr. Joseph Wu laboratory at the Stanford Cardiovascular Institute (Stanford University) in California (US) to investigate arrhythmias and cardiovascular diseases using human induced pluripotent stem cell (hiPSC) technology. In June 2021, she was award by the American Heart Association (AHA) postdoctoral grant. She was awarded by the Pharmacology Spanish Society with the Young Investigator Award in 2022. Finally, in September 2023 she joined Dr. José Jalife laboratory where she is focused in the study of electrophysiological underlying mechanisms of arrhythmogenic inheritable cardiac diseases such as Long QT Syndromes and Andersen Tawil Syndrome, among others.
